bupropion has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 4 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Disruptive, Impulse Control, and Conduct Disorders: Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pathological gambling is substantially more prevalent among cocaine-dependent outpatients than in the general population." | 2.69 | Pathological gambling among cocaine-dependent outpatients. ( Carriero, NJ; Gorelick, DA; Hall, GW; Montoya, ID; Preston, KL; Takushi, RY, 2000) |
| "Pathological gambling is frequently comorbid with bipolar spectrum disorders, substance abuse/dependence, and attention-deficit/hyperactivity disorder (ADHD), and comorbidity may influence treatment response in pathological gambling." | 2.43 | Pharmacological treatments of pathological gambling. ( Baker, B; Baldini-Rossi, N; Hollander, E; Pallanti, S; Sood, E, 2005) |
| "Bupropion-treated smokers had smaller cigarette cue-induced increases in craving scores on the Urge to Smoke (UTS) Scale and less activation of perigenual/ventral ACC metabolism from the neutral to the cigarette cue scan than untreated smokers." | 1.32 | Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study. ( Brody, AL; Jarvik, ME; Lee, G; London, ED; Mandelkern, MA; Sadeghi, M; Saxena, S; Smith, E, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tidey, JW | 1 |
| Rohsenow, DJ | 1 |
| Brody, AL | 1 |
| Mandelkern, MA | 1 |
| Lee, G | 1 |
| Smith, E | 1 |
| Sadeghi, M | 1 |
| Saxena, S | 1 |
| Jarvik, ME | 1 |
| London, ED | 1 |
| Hollander, E | 1 |
| Sood, E | 1 |
| Pallanti, S | 1 |
| Baldini-Rossi, N | 1 |
| Baker, B | 1 |
| Hall, GW | 1 |
| Carriero, NJ | 1 |
| Takushi, RY | 1 |
| Montoya, ID | 1 |
| Preston, KL | 1 |
| Gorelick, DA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effects of Glycine Transport Inhibition on Brain Glycine Concentration[NCT00538070] | 68 participants (Actual) | Interventional | 2007-08-31 | Completed | |||
| The STOP Study: Real World Effectiveness of Zyban Treatment in a Clinical Population[NCT01015170] | Phase 4 | 454 participants (Actual) | Interventional | 2009-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"Number of participants who report Not Smoking (not even a puff) in past 7 days when asked at week 8" (NCT01015170)
Timeframe: End of Treatment (8 weeks after Zyban start date)
| Intervention | participants (Number) | |
|---|---|---|
| Still smoking | Quit smoking | |
| Nicotine Replacement & Behavioural Support | 109 | 106 |
1 review available for bupropion and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Pharmacological treatments of pathological gambling.
Topics: Antidepressive Agents, Second-Generation; Behavior, Addictive; Bupropion; Comorbidity; Disruptive, I | 2005 |
1 trial available for bupropion and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Pathological gambling among cocaine-dependent outpatients.
Topics: Adolescent; Adult; Age of Onset; Ambulatory Care; Bromocriptine; Bupropion; Carbamazepine; Cocaine-R | 2000 |
2 other studies available for bupropion and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Intention to quit moderates the effect of bupropion on smoking urge.
Topics: Adult; Bupropion; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Intention; Mal | 2009 |
Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study.
Topics: Adult; Bupropion; Cues; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Uptake Inhibito | 2004 |
Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study.
Topics: Adult; Bupropion; Cues; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Uptake Inhibito | 2004 |
Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study.
Topics: Adult; Bupropion; Cues; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Uptake Inhibito | 2004 |
Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study.
Topics: Adult; Bupropion; Cues; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Uptake Inhibito | 2004 |